US Stock MarketDetailed Quotes

CADL Candel Therapeutics

Watchlist

4.960
+0.340+7.36%

Trading Nov 27 15:54 ET

161.08MMarket Cap-2867P/E (TTM)

Candel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Candel Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2023/Q4	0.000 / 0.000	--
--	2023/Q3	0.000 / 0.000	--
--	2023/Q2	0.000 / 0.000	--
--	2022/Q4	31.000K / 14.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2023/Q40.000 / 0.000--

--2023/Q30.000 / 0.000--

--2023/Q20.000 / 0.000--

--2022/Q431.000K / 14.000K--

Unlock Free Earnings Estimates

Open Account

Candel Therapeutics Earnings Reports

Candel Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14 08:37 ET

Candel Therapeutics | 8-K: Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Nov 14 08:21 ET

Candel Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 08:32 ET

Candel Therapeutics | 8-K: Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Aug 13 08:17 ET

Analyst Rating

Updated: Nov 18, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall